clofibric acid has been researched along with Diabetic Retinopathy in 3 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Etofibrate treatment also produced significant improvements in total cholesterol, LDL-cholesterol and HDL-cholesterol in comparison to the placebo treatment group." | 6.74 | [Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy]. ( Emmerich, KH; Erbler, H; Goldsteine, J; Görtelmeyer, R; Klindzane, M; Poritis, N; Stelmane, I, 2009) |
| "Etofibrate treatment also produced significant improvements in total cholesterol, LDL-cholesterol and HDL-cholesterol in comparison to the placebo treatment group." | 2.74 | [Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy]. ( Emmerich, KH; Erbler, H; Goldsteine, J; Görtelmeyer, R; Klindzane, M; Poritis, N; Stelmane, I, 2009) |
| "Greater than 60% of patients with type 2 diabetes will have retinopathy." | 2.44 | Update on the treatment of diabetic retinopathy. ( Miller, AG; Wilkinson-Berka, JL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emmerich, KH | 1 |
| Poritis, N | 1 |
| Stelmane, I | 1 |
| Klindzane, M | 1 |
| Erbler, H | 1 |
| Goldsteine, J | 1 |
| Görtelmeyer, R | 1 |
| Wilkinson-Berka, JL | 1 |
| Miller, AG | 1 |
| Freyberger, H | 1 |
| Schifferdecker, E | 1 |
| Schatz, H | 1 |
1 review available for clofibric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Update on the treatment of diabetic retinopathy.
Topics: Adrenal Cortex Hormones; Aldehyde Reductase; Angiotensin II; Antihypertensive Agents; Blood Glucose; | 2008 |
1 trial available for clofibric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
[Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy].
Topics: Administration, Oral; Adolescent; Adult; Aged; Clofibric Acid; Diabetic Retinopathy; Double-Blind Me | 2009 |
1 other study available for clofibric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].
Topics: Adult; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundu | 1994 |